Skip to content

Comparison of hhCG With hCG+ß in the Early Prediction of Ongoing Pregnancy.

Comparison of hhCG With hCG+ß in the Early Prediction of Ongoing Pregnancy After In-vitro Fertilization and Embryo Transfer.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03184519
Acronym
hyperPOC
Enrollment
156
Registered
2017-06-12
Start date
2017-06-19
Completion date
2018-08-10
Last updated
2020-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy Test

Brief summary

Proof of concept study for the prediction of ongoing pregnancy in women undergoing In-Vitro Fertilization (IVF), using hyperglycosylated human chorionic gonadotropin (hhCG), early after In-Vitro Fertilization and fresh Embryo Transfer (IVF-ET).

Interventions

DIAGNOSTIC_TESTPregnancy test

Instead of one blood sample, patients will have three blood analyses to predict pregnancy earlier after the embryo transfer.

Sponsors

Instituto Valenciano de Infertilidad, IVI VALENCIA
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

All the patients will undergo 3 blood samples for analyses to determine pregnancy.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Written informed consent * Patients undergoing their first or second IVF-ET cycle * Age 18-45 years * Use of Ovitrelle for final follicular maturation and luteinization * Fresh or Frozen day-5 blastocysts transrer (Autologus or Egg donation)

Exclusion criteria

* Gestational surrogacy (patient's eggs used for pregnancy in a surrogate mother) * Canceled IVF cycles * GnRH agonist triggering cycles in the case of fresh ET.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Early Detection of PregnancyOne monthDetection of Pregnancy on earlier dates (before day-11 after Embrio transfer)

Countries

Spain

Participant flow

Participants by arm

ArmCount
All Patients
Patients will undergo 3 blood samples after IVF-ET (pregnancy test) to determine pregnancy. Pregnancy test: Instead of one blood sample, patients will have three blood analyses to predict pregnancy earlier after the embryo transfer.
155
Total155

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up6
Overall StudyPhysician Decision21

Baseline characteristics

CharacteristicAll Patients
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
155 Participants
Age, Continuous39 years
Race/Ethnicity, Customized
ARAB NORTH
1 Participants
Race/Ethnicity, Customized
CAUCASIAN
155 Participants
Race/Ethnicity, Customized
hispanic/latino
2 Participants
Race/Ethnicity, Customized
not hispanic/latino
153 Participants
Region of Enrollment
Spain
155 Participants
Sex/Gender, Customized
female
155 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 156
other
Total, other adverse events
0 / 156
serious
Total, serious adverse events
0 / 156

Outcome results

Primary

Number of Participants With Early Detection of Pregnancy

Detection of Pregnancy on earlier dates (before day-11 after Embrio transfer)

Time frame: One month

Population: From the 155 patients, 13 were excluded from analysis for several issues.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
All PatientsNumber of Participants With Early Detection of Pregnancy142 Participants
p-value: 0.025t-test, 1 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026